EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis

Ádám Szilágyi, Petra Varga, Gergely Agócs, Tamás Kói, Márk Hernádfői, Ximeng Li, Attila Kovács, Szilárd Váncsa, Klementina Ocskay, Péter Hegyi, Miklós Garami

European Journal of Cancer · 2026-12 · 249 · 117820

DOI: 10.1016/j.ejca.2026.117820 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Cancer, 2026-12. Verfasst von Ádám Szilágyi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Medicine, Semmelweis University, Baross utca 22, Budapest 1085, Hungary. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaAdverse eventsChimeric antigen receptor T-cell therapyComplete responseMultiple myelomaNon-Hodgkin lymphomaOverall survival

Autor:innen und Institutionen

  • Centre for Translational Medicine, Semmelweis University, Baross utca 22, Budapest 1085, Hungary.
  • Centre for Translational Medicine, Semmelweis University, Baross utca 22, Budapest 1085, Hungary; Heim Pál National Pediatric Institute, Üllői út 86, Budapest 1089, Hungary.
  • Centre for Translational Medicine, Semmelweis University, Baross utca 22, Budapest 1085, Hungary; Department of Biophysics and Radiation Biology, Semmelweis University, Tűzoltó utca 37-47, Budapest 1094, Hungary.
  • Centre for Translational Medicine, Semmelweis University, Baross utca 22, Budapest 1085, Hungary; Department of Stochastics, Institute of Mathematics, Budapest University of Technology and Economics, Egry József utca 1,…
  • Centre for Translational Medicine, Semmelweis University, Baross utca 22, Budapest 1085, Hungary; Bethesda Children's Hospital, Bethesda utca 3, Budapest 1146, Hungary.
  • University of Debrecen, Egyetem tér 1, Debrecen 4032, Hungary.

Zitieren

APA

Szilágyi, Á., Varga, P., Agócs, G., Kói, T., Hernádfői, M., Li, X., Kovács, A., Váncsa, S., Ocskay, K., Hegyi, P., & Garami, M. (2026). Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis. European Journal of Cancer, 249, 117820. https://doi.org/10.1016/j.ejca.2026.117820

Vancouver

Szilágyi Á, Varga P, Agócs G, Kói T, Hernádfői M, Li X, et al. Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis. European Journal of Cancer. 2026;249:117820. doi:10.1016/j.ejca.2026.117820

BibTeX
@article{Szilgyi2026,
  author = {Szilágyi, Ádám and Varga, Petra and Agócs, Gergely and Kói, Tamás and Hernádfői, Márk and Li, Ximeng and Kovács, Attila and Váncsa, Szilárd and Ocskay, Klementina and Hegyi, Péter and Garami, Miklós},
  title = {Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {249},
  pages = {117820},
  doi = {10.1016/j.ejca.2026.117820}
}
Kostenlos starten →